Sivaprasad, Sobha
Ghanchi, Faruque http://orcid.org/0000-0002-4448-8162
Kelly, Simon P.
Kotagiri, Ajay
Talks, James
Scanlon, Peter http://orcid.org/0000-0001-8513-710X
McGoey, Hellen http://orcid.org/0000-0002-9579-9390
Nolan, Andrew http://orcid.org/0000-0003-0799-2914
Saddiq, Moneeb
Napier, Jackie
Funding for this research was provided by:
This study was sponsored by Bayer Plc, Reading.
Article History
Received: 22 June 2022
Revised: 16 September 2022
Accepted: 16 January 2023
First Online: 20 March 2023
Competing interests
: SS received consultancy fees from Bayer, Allergan, Novartis Pharma AG, Roche, Boehringer Ingelheim, Optos, Apellis, Oxurion, Biogen, Oculis and Heidelberg Engineering. SS is Editor-in-Chief for the Journal Eye. FG has been a consultant and/or speaker for Novartis, Bayer, Boehringer Ingelheim, Allergan, Apellis, Heidelberg and Roche; and has received travel support from Roche and Novartis. Simon P Kelly is a consultant for Roche; received travel grants from Bayer; research support from Bayer and Novartis; and participated in advisory boards for Novartis and Polyphotopics. AK received travel support from Novartis, Bayer, and Allergan; and speaker fees from Allergan and Bayer. JT participated in advisory boards for Bayer and Novartis; received travel support from Bayer; and received research grants from Bayer, Novartis and Roche. PS attended advisory boards for Pfizer, Allergan, Boehringer, Roche and Bayer; and his department has received educational, research; and audit grants from Allergan, Boehringer Ingelheim, Novartis and Bayer. HM is an employee of Bayer Plc. AN was formerly an employee of Bayer Plc, now employed at Ipsen UK Ltd. MS is an employee of O4 Research. JN is an employee of Bayer Plc.